These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9303612)
1. [Dysfunction of a TIPS (transjugular intrahepatic porto-systemic shunt) and chylous ascites]. Rovira E; Molés JR; Hinojosa J; Primo J; Gonzalvo F; Albert A Rev Esp Enferm Dig; 1997 Jun; 89(6):475-7. PubMed ID: 9303612 [TBL] [Abstract][Full Text] [Related]
2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397 [TBL] [Abstract][Full Text] [Related]
3. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Colombato L J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487 [TBL] [Abstract][Full Text] [Related]
4. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Attwell A; Ludkowski M; Nash R; Kugelmas M Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358 [TBL] [Abstract][Full Text] [Related]
6. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219 [TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. Russo MW; Jacques PF; Mauro M; Odell P; Brown RS Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573 [TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916 [TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841 [TBL] [Abstract][Full Text] [Related]
10. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Sauer P; Hansmann J; Richter GM; Stremmel W; Stiehl A Endoscopy; 2002 Sep; 34(9):690-7. PubMed ID: 12195325 [TBL] [Abstract][Full Text] [Related]
11. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. Membreno F; Baez AL; Pandula R; Walser E; Lau DT J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494 [TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Bilbao JI; Quiroga J; Herrero JI; Benito A Cardiovasc Intervent Radiol; 2002; 25(4):251-69. PubMed ID: 12324815 [TBL] [Abstract][Full Text] [Related]
13. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney. Hamel B; Guillaud O; Roman S; Vallin M; Pilleul F; Valette PJ; Henry L; Guibal A; Mion F; Dumortier J Dig Liver Dis; 2014 Nov; 46(11):1001-7. PubMed ID: 25096966 [TBL] [Abstract][Full Text] [Related]